Cargando…
Tissue-resident memory T cells in immune-related adverse events: friend or foe?
Many cancer patients experience toxicity during checkpoint blockade immunotherapy, which often leads to treatment discontinuation. To this end, understanding the mechanisms mediating immune-related adverse events (irAE) should ultimately enable improvement in clinical outcomes. Recent work has revea...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078118/ https://www.ncbi.nlm.nih.gov/pubmed/37035636 http://dx.doi.org/10.1080/2162402X.2023.2197358 |